Mumbai (Maharashtra) [India], August 30: Amanta Healthcare Limited, (“Amanta”, “the Company”) engaged in the development, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals, secured ₹37.80 crore through its anchor book process on August 29, 2025. According to the exchange filing 06 investors participated in the anchor book offering.
Also Read | Samsung Electronics and SK Hynix Stripped of VEU Status by US, Required To Obtain Licenses for Sending Chipmaking Equipment to China.
Also Read | Who is Auqib Nabi? Know All About Jammu and Kashmir Pacer Who Took Hat-Trick in North Zone vs East Zone Match in Duleep Trophy 2025.
5. Sunrise Investment Trust- Sunrise Investment Opportunities Fund
6. Finavenue Capital Trust- Finavenue Growth Fund
Amanta Healthcare Limited has allocated a total of 30,00,000Equity Shares to these anchor investors, with each share priced at ₹ 126.
Beeline Capital Advisors Private Limited is the Book Running Lead Manager to the Issue, while MUFG Intime India Private Limited is Registrar to the Issue.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN. ANI will not be responsible in any way for the content of the same)
(The above story is verified and authored by ANI staff, ANI is South Asia’s leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)
